Jim Cramer on Gilead Sciences, Inc. (GILD): ‘I Don’t Think The Business Is Worth...

Published on 27 Dec 2024 on Insider Monkey · via Yahoo Finance

We recently compiled a list of the Jim Cramer Talked About These 8 Stocks. In this article, we are...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the Top 20 Dividend Stocks of 2024. In this article, we are going ...

Insider Monkey · via Yahoo Finance 31 Dec 2024

Berkshire Hathaway returned to load up on one particular tech stock. Meanwhile, other insiders...

247wallst.com 29 Dec 2024

We recently compiled a list of the Jim Cramer Talked About These 8 Stocks. In this article, we ar...

Insider Monkey · via Yahoo Finance 27 Dec 2024

Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops and...

Benzinga · via Yahoo Finance 25 Dec 2024

A Fremont pharmaceutical company received an investment of approximately $50 million — about $3.5...

The Business Journals 24 Dec 2024

Gilead Sciences invests $20.1 million in Assembly Biosciences

Investing.com 23 Dec 2024

Polaris Capital Management, an investment management company, released its third quarter 2024 inv...

Insider Monkey · via Yahoo Finance 23 Dec 2024

Free Report) has put up a steady performance in 2024 amid a volatile market. Gilead has a...

Zacks 20 Dec 2024

This deal is expected to reduce Gilead’s 2024 GAAP and non-GAAP EPS by about 1 cent. Gilead...

Zacks · via Yahoo Finance 18 Dec 2024

It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among...

Zacks · via Yahoo Finance 18 Dec 2024